Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 207.54 billion. The enterprise value is 281.55 billion.

Market Cap	207.54B
Enterprise Value	281.55B

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.75%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 19.48 and the forward PE ratio is 8.99.

PE Ratio	19.48
Forward PE	8.99
PS Ratio	2.42
PB Ratio	1.74
P/TBV Ratio	n/a
P/FCF Ratio	16.68
P/OCF Ratio	12.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.76, with an EV/FCF ratio of 22.63.

EV / Earnings	26.42
EV / Sales	3.30
EV / EBITDA	7.76
EV / EBIT	10.79
EV / FCF	22.63

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.14M
Profits Per Employee	142,066
Employee Count	75,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-364.72M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.70%
50-Day Moving Average	12.24
200-Day Moving Average	11.65
Relative Strength Index (RSI)	40.70
Average Volume (20 Days)	190,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.24

Income Statement

In the last 12 months, Pfizer had revenue of CAD 85.80 billion and earned 10.65 billion in profits. Earnings per share was 1.87.

Revenue	85.80B
Gross Profit	65.04B
Operating Income	26.28B
Pretax Income	10.31B
Net Income	10.65B
EBITDA	35.26B
EBIT	26.28B
Earnings Per Share (EPS)	1.87

Balance Sheet

The company has 18.64 billion in cash and 92.75 billion in debt, giving a net cash position of -74.11 billion.

Cash & Cash Equivalents	18.64B
Total Debt	92.75B
Net Cash	-74.11B
Net Cash Per Share	n/a
Equity (Book Value)	118.98B
Book Value Per Share	20.85
Working Capital	8.11B

Cash Flow

In the last 12 months, operating cash flow was 16.05 billion and capital expenditures -3.60 billion, giving a free cash flow of 12.44 billion.

Operating Cash Flow	16.05B
Capital Expenditures	-3.60B
Depreciation & Amortization	8.96B
Net Borrowing	-101.13M
Free Cash Flow	12.44B
FCF Per Share	n/a

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 0.78, which amounts to a dividend yield of 6.53%.

Dividend Per Share	0.78
Dividend Yield	6.53%
Dividend Growth (YoY)	-0.46%
Years of Dividend Growth	2
Payout Ratio	41.51%
Buyback Yield	-0.23%
Shareholder Yield	6.12%
Earnings Yield	5.13%
FCF Yield	6.00%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6